J9347 Injection, tremelimumab-actl, 1 milligrams
J-Codes
Also known as: tremelimumab, Imjudo
Injection of tremelimumab-actl, 1 milligram. A cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) checkpoint inhibitor monoclonal antibody.
Clinical Context
Used for hepatocellular carcinoma with durvalumab (PD-L1 inhibitor). CTLA-4 blockade enhances T-cell activation.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.